cjc 1295 dac

CJC-1295 (WITH DAC)

$33.99
Out of stock

What is CJC-1295 (With DAC)?

CJC-1295 (With DAC) is a synthetic analog of growth hormone–releasing hormone (GHRH) intended for laboratory investigation of receptor-binding characteristics and associated intracellular signaling mechanisms. The inclusion of DAC (Drug Affinity Complex) is studied for its effect on extending compound stability and research half-life under controlled experimental conditions.

Mechanism of Research Interest

CJC-1295 (With DAC) is examined in vitro and in non-clinical models to evaluate interaction with GHRH receptor systems and downstream signaling pathways. The DAC component is analyzed for its role in altering peptide binding behavior and resistance to degradation in laboratory settings.

Why Researchers Study CJC-1295 (With DAC)

  • To analyze receptor-binding affinity in controlled laboratory assays
  • To evaluate intracellular signaling responses in experimental models
  • To investigate structural stability and compound behavior under research conditions
Research Use Only: This product is supplied strictly for laboratory and analytical research purposes. It is not for human or animal use, not a medicine, and not intended for diagnostic, therapeutic, or clinical applications.

Published Research References

The following peer-reviewed publications provide context for the scientific investigation of this compound. These references are provided for informational purposes only.

  1. Teichman SL, Neale A, Lawrence B, et al. (2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805. PMID: 16352683
  2. Alba M, Fintini D, Sagazio A, et al. (2006). “Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.” American Journal of Physiology, 291(6), E1290-E1294. PMID: 16822960
  3. Jette L, Leger R, Thibaudeau K, et al. (2005). “Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats.” Endocrinology, 146(7), 3052-3058. PMID: 15817669

Research Background

CJC-1295 with Drug Affinity Complex (CJC-1295 (WITH DAC)) is a synthetic analog of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) that facilitates albumin binding. It has been examined in laboratory research for its interaction with GHRH receptor signaling and its extended half-life characteristics.

Laboratory Research Areas

In published scientific literature, CJC-1295 (WITH DAC) has been explored in the following research contexts:

  • GHRH receptor binding and activation in in vitro assays
  • Albumin-binding kinetics and extended half-life characterization
  • Growth hormone axis signaling in preclinical models
  • Peptide-DAC conjugation stability and structural analysis

Product Specifications

  • Form: Lyophilized powder
  • Storage: Store at -20°C, protect from light
  • Brand: Alpha Peptides
  • Purity: ≥98% (verified by HPLC)

Quality & Testing Transparency

Every batch of CJC-1295 (WITH DAC) supplied by Alpha Peptides is accompanied by third-party analytical testing documentation. Our Certificates of Analysis (COAs) verify compound identity via mass spectrometry and purity via HPLC analysis. View our published testing records on the Certificates of Analysis page.

Related Research Compounds

Researchers investigating this compound may also be interested in the following related research peptides:

Attributes Value
Weight
Dimensions
Dosage

5 MG
Brand

Alpha Peptides

CJC-1295 (With DAC)
CJC-1295 (With DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog intended for laboratory investigation of receptor-binding characteristics and associated intracellular signaling pathways. The DAC (Drug Affinity Complex) component is studied for its influence on compound stability and extended research half-life in controlled experimental environments.
For Research Use Only • Not for Human or Animal Use

Strictly for Laboratory Research
This compound is supplied exclusively for in vitro and non-clinical laboratory research. It is not intended for human or animal use, not a medicine, and not for diagnostic, therapeutic, or clinical applications.
Research Acknowledgment: The purchaser represents that this material will be used solely for legitimate laboratory research purposes and will be handled in accordance with applicable laws and laboratory safety standards.
Terms of Purchase
By purchasing from Alpha Peptides & ALPHAPEP LLC, you confirm that you are a qualified research entity or professional with the facilities and expertise required to safely handle research materials. The supplier assumes no liability for misuse or improper handling of this product.

Related Products